Creation and characterization of a cell-death reporter cell line for hepatitis C virus infection

Antiviral Research

Volumn 86, Issue 2, 2010, Pages 220-223

  Chen, Zhilei ^a,b   Simeon, Rudo L ^b   Chockalingam, Karuppiah ^b   Rice, Charles M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Department of Electrical and Computer Engineering   (United States)

Author keywords

Cytopathic effect; Enrichment; Genetic selection; N4mBid (hepatoma cell line); Plaque assay

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; PROTEIN BID; SHORT HAIRPIN RNA;

ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENRICHMENT CULTURE; HEPATITIS C VIRUS; HEPATOMA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS LOAD;

CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; HEPACIVIRUS; HEPATOCYTES; HUMANS; VIROLOGY;

HEPATITIS C VIRUS;

EID: 77951298745     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.02.321     Document Type: Article

References (25)

1. Alter H.J., Seeff L.B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 2000, 20:17-35.
2. Blight K.J., McKeating J.A., Rice C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 2002, 76:13001-13014.
3. Bukh J., Pietschmann T., Lohmann V., Krieger N., Faulk K., Engle R.E., Govindarajan S., Shapiro M., St Claire M., Bartenschlager R. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:14416-14421.
4. Carroll S.S., Tomassini J.E., Bosserman M., Getty K., Stahlhut M.W., Eldrup A.B., Bhat B., Hall D., Simcoe A.L., LaFemina R., Rutkowski C.A., Wolanski B., Yang Z., Migliaccio G., De Francesco R., Kuo L.C., MacCoss M., Olsen D.B. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. J. Biol. Chem. 2003, 278:11979-11984.
5. Chen S.H., Tan S.L. Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection. Curr. Med. Chem. 2005, 12:2317-2342.
6. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
7. Cory S., Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2:647-656.
8. Gottwein J.M., Scheel T.K., Hoegh A.M., Lademann J.B., Eugen-Olsen J., Lisby G., Bukh J. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 2007, 133:1614-1626.
9. Hsu E.C., Hsi B., Hirota-Tsuchihara M., Ruland J., Iorio C., Sarangi F., Diao J., Migliaccio G., Tyrrell D.L., Kneteman N., Richardson C.D. Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers. Nat. Biotechnol. 2003, 21:519-525.
10. Ikeda M., Yi M., Li K., Lemon S.M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 2002, 76:2997-3006.
11. Lindenbach B.D., Evans M.J., Syder A.J., Wölk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
12. Lindenbach B.D., Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436:933-938.
13. Marukian S., Jones C.T., Andrus L., Evans M.J., Ritola K.D., Charles E.D., Rice C.M., Dustin L.B. Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 2008, 48:1843-1850.
14. Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L., Bartenschlager R. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7408-7413.
15. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., Bartenschlager R. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 2002, 76:4008-4021.
16. Sirven A., Ravet E., Charneau P., Zennou V., Coulombel L., Guétard D., Pflumio F., Dubart-Kupperschmitt A. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol. Ther. 2001, 3:438-448.
17. Strasser A. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 2005, 5:189-200.
18. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
19. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z.J., Murthy K., Habermann A., Kräusslich H.G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11:791-905.
20. Wasley A., Alter M.J. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin. Liver Dis. 2000, 20:1-16.
21. Wiznerowicz M., Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 2003, 77:8957-8961.
22. Zennou V., Petit C., Guetard D., Nerhbass U., Montagnier L., Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101:173-185.
23. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9294-9299.
24. Zhong J., Gastaminza P., Chung J., Stamataki Z., Isogawa M., Cheng G., McKeating J.A., Chisari F.V. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 2006, 80:11082-11093.
25. Zimmermann K.C., Bonzon C., Green D.R. The machinery of programmed cell death. Pharmacol. Ther. 2001, 92:57-70.